CHE

$546.870.86%4.685

Chemed Corp (CHE)

Date: O: H: L: C: Vol:

Chemed Corp stock is traded at $546.87, with a volume of 19,980. It is up +0.86% in the last 24 hours and up +7.76% over the past month. Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. The company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.

Previous Close:

$542.18

Open:

$540.00

24h Volume:

19,980

Relative Volume:

0.12

Market Cap:

$7.09B

Revenue:

$2.54B

Net Income/Loss:

$259.78M

P/E Ratio:

29.80

EPS:

$18.35

Net Cash Flow:

$377.12M

1W Performance:

+7.42%

1M Performance:

+7.76%

6M Performance:

+29.54%

1Y Performance:

+24.10%

1-Day Range:

$539.57$548.27

1-Week Range:

$527.09$562.24

52-Week Range:

$365.21$562.24

Chemed Corp Stock (CHE) Company Profile

Name

Chemed Corp

Sector

Healthcare

Industry

Medical Care Facilities

Phone

(513)762-6690

Address

SUITE 2600, CINCINNATI, OH, USA

Employee

15,811

Next Earnings Date

null

Latest SEC Filings

SEC

CHE's Discussions on X

Market Cap

Revenue

Net Income

Cash Flow

EPS

Chemed Corp Stock (CHE) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-28-26	Upgrade	Jefferies	Hold → Buy
Sep-25-26	Initiated	UBS	Buy
Feb-27-26	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jan-22-26	Downgrade	Jefferies	Buy → Hold
Sep-02-25	Upgrade	Jefferies	Hold → Buy
Jul-25-25	Initiated	Jefferies	Hold
Mar-11-20	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Nov-01-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform
Sep-06-19	Reiterated	BofA/Merrill	Buy
Oct-12-18	Initiated	BofA/Merrill	Buy
Aug-28-17	Initiated	KeyBanc Capital Mkts	Sector Weight
Nov-01-16	Reiterated	RBC Capital Mkts	Sector Perform
Jul-27-16	Reiterated	RBC Capital Mkts	Sector Perform
May-02-16	Reiterated	RBC Capital Mkts	Sector Perform
Oct-26-15	Reiterated	Oppenheimer	Outperform
Oct-26-15	Reiterated	RBC Capital Mkts	Sector Perform
Sep-22-15	Reiterated	Oppenheimer	Outperform
Jul-27-15	Reiterated	RBC Capital Mkts	Sector Perform
Feb-19-15	Reiterated	Oppenheimer	Outperform
Sep-23-14	Reiterated	Oppenheimer	Outperform
Jun-10-14	Reiterated	RBC Capital Mkts	Sector Perform
May-01-14	Reiterated	Oppenheimer	Outperform
Sep-10-13	Reiterated	Deutsche Bank	Hold
Mar-04-11	Reiterated	Barclays Capital	Underweight
Feb-17-11	Reiterated	Oppenheimer	Outperform
Feb-17-11	Reiterated	RBC Capital Mkts	Sector Perform

Chemed Corp Stock (CHE) Financials Data

Period	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period End Date	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Revenue USD (M)	2,529.98	2,431.29	2,264.42	2,134.96	2,139.26
Cost of revenue USD (M)	1,706.79	1,576.94	1,465.60	1,369.88	1,369.46
Gross profit USD (M)	-	-	798.82	765.09	769.80
Operating expenses USD (M)	2,191.73	2,064.79	458.25	421.59	426.77
Operating income USD (M)	338.25	366.49	340.57	343.50	343.04
Income before tax USD (M)	355.78	399.47	350.37	329.68	350.31
Income tax expense USD (M)	90.54	97.47	77.86	80.06	81.76
Net income USD (M)	265.24	302.00	272.51	249.62	268.55
Basic EPS USD/shares	18.42	20.10	18.11	16.72	17.14
Diluted EPS USD/shares	18.34	19.89	17.93	16.53	16.85
Basic weighted shares shares (M)	14.40	15.02	15.05	14.93	15.67
Diluted weighted shares shares (M)	14.46	15.19	15.20	15.10	15.94
Selling, general and administrative USD (M)	417.19	424.36	395.12	358.73	366.73

Chemed Corp Stock (CHE) Insider Trading

LEE SPENCER SSep 30 '26
executive vice president
Transaction
Option Exercise
Cost
$445.35
#Shares
12,099
Value ($)
5,388,290
#Shares Total
26,011
HUTTON THOMAS CSep 28 '26
vice president
Transaction
Option Exercise
Cost
$445.35
#Shares
4,629
Value ($)
2,061,525
#Shares Total
37,110
MCNAMARA KEVIN JSep 28 '26
president and CEO
Transaction
Sale
Cost
$513.45
#Shares
2,000
Value ($)
1,026,900
#Shares Total
66,418
Kevin McNamaraSep 28 '26
Officer
Transaction
Proposed Sale
Cost
$536.13
#Shares
2,000
Value ($)
1,072,260
#Shares Total
0
MCNAMARA KEVIN JSep 18 '26
Officer
Transaction
Proposed Sale
Cost
$499.00
#Shares
2,000
Value ($)
998,000
#Shares Total
0
MCNAMARA KEVIN JSep 18 '26
president and CEO
Transaction
Sale
Cost
$501.40
#Shares
2,000
Value ($)
1,002,800
#Shares Total
68,418
MCNAMARA KEVIN JAug 21 '26
president and CEO
Transaction
Sale
Cost
$541.16
#Shares
2,000
Value ($)
1,082,320
#Shares Total
70,418
LEE SPENCER SAug 21 '26
executive vice president
Transaction
Sale
Cost
$541.04
#Shares
1,000
Value ($)
541,040
#Shares Total
13,912
Kevin J McNamaraAug 21 '26
Officer
Transaction
Proposed Sale
Cost
$539.34
#Shares
2,000
Value ($)
1,078,680
#Shares Total
0
Judkins Brian CAug 10 '26
VP and Chief Legal Officer
Transaction
Option Exercise
Cost
$445.35
#Shares
6,786
Value ($)
3,022,145
#Shares Total
9,222

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
LEE SPENCER S	executive vice president	Sep 30 '26	Option Exercise	$445.35	12,099	5,388,290	26,011
HUTTON THOMAS C	vice president	Sep 28 '26	Option Exercise	$445.35	4,629	2,061,525	37,110
MCNAMARA KEVIN J	president and CEO	Sep 28 '26	Sale	$513.45	2,000	1,026,900	66,418
Kevin McNamara	Officer	Sep 28 '26	Proposed Sale	$536.13	2,000	1,072,260	0
MCNAMARA KEVIN J	Officer	Sep 18 '26	Proposed Sale	$499.00	2,000	998,000	0
MCNAMARA KEVIN J	president and CEO	Sep 18 '26	Sale	$501.40	2,000	1,002,800	68,418
MCNAMARA KEVIN J	president and CEO	Aug 21 '26	Sale	$541.16	2,000	1,082,320	70,418
LEE SPENCER S	executive vice president	Aug 21 '26	Sale	$541.04	1,000	541,040	13,912
Kevin J McNamara	Officer	Aug 21 '26	Proposed Sale	$539.34	2,000	1,078,680	0
Judkins Brian C	VP and Chief Legal Officer	Aug 10 '26	Option Exercise	$445.35	6,786	3,022,145	9,222

Similar to CHE